CRISPR Therapeutics AG (CRSP)
53.46
-1.18
(-2.16%)
USD |
NASDAQ |
Feb 20, 16:00
53.79
+0.33
(+0.62%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap : 5.131B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 121.15B |
| Beam Therapeutics, Inc. | 2.800B |
| Novartis AG | 310.40B |
| Recursion Pharmaceuticals, Inc. | 1.780B |
| EvoNext Holdings SA | 7.933M |
Market Cap Related Metrics
| PS Ratio | 1369.18 |
| PEG Ratio | -0.1659 |
| Price to Book Value | 2.670 |
| Price | 53.46 |
| Earnings Yield | -12.19% |
| PEGY Ratio | -0.1659 |